Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eplerenone for early diabetic heart disease in type 2 diabetes
ACTRN12610001063000Phase 2Completed
- Sponsor
- Royal Liverpool University Hospital
- Start
- Nov 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing Eplerenone with Placebo (2 arms). Primary endpoints: Left ventricular and left atrial function by echocardiogram ultrasound, Degree of scarring of the left ventricle and left atrium by echocardiography and 1 more. Started Nov 2011; status: completed.
02
Drugs
eplerenone
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ACTRN12610001063000.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12610001063000.